CUA Educational Content

Bladder Cancer Forum 2023

Recording from March 31 - April 1, 2023 / Kingston, Ontario



    Meeting Co-Chairs

    Madhuri Koti
    Queen’s Cancer Research Institute
    Srikala Sridhar
    UHN, Department of Medical Oncology

    Steering Committee

    David Berman
    Queen’s University, Department of Pathology and Molecular Medicine
    Peter Black
    Vancouver Prostate Centre
    Tony Cornacchia
    Bladder Cancer Canada
    Wassim Kassouf
    McGill University, Department of Surgery, Division of Urology
    Girish Kulkarni
    University of Toronto, Department of Surgery, Division of Urology
    Robert Purves
    Bladder Cancer Canada
    Robert Siemens
    Queen’s University, Department of Urology

    Learning Objectives

    • Understand the current state of knowledge on the BCG mode of action and novel immunotherapies beyond BCG for NMIBC
    • Understand current and emerging imaging approaches in NMIBC and MIBC
    • Understand how biomarkers are being incorporated into the management of metastatic urothelial cancer (mUC) and discuss clinical management of mUC cases
    • Understand novel immune evasion mechanisms underlying bladder cancer progression and novel therapies targeting them
    • Understand novel immune-based approaches in preclinical and early clinical stages of evaluation in bladder cancer

    View final program >>